284 related articles for article (PubMed ID: 35549357)
1. Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations.
Lin EP; Chin BB; Fishbein L; Moritani T; Montoya SP; Ellika S; Newlands S
Radiol Imaging Cancer; 2022 May; 4(3):e210088. PubMed ID: 35549357
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Janssen I; Chen CC; Taieb D; Patronas NJ; Millo CM; Adams KT; Nambuba J; Herscovitch P; Sadowski SM; Fojo AT; Buchmann I; Kebebew E; Pacak K
J Nucl Med; 2016 Feb; 57(2):186-91. PubMed ID: 26564322
[TBL] [Abstract][Full Text] [Related]
3. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
[TBL] [Abstract][Full Text] [Related]
5. Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment.
Rana MU; Østhus AA; Heimdal K; Jebsen P; Revheim MR; Osnes TA
Acta Otolaryngol; 2021 Mar; 141(3):303-308. PubMed ID: 33320715
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
7. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
8. Superiority of
Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
[TBL] [Abstract][Full Text] [Related]
9. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
[TBL] [Abstract][Full Text] [Related]
10. Hereditary head and neck paraganglioma: from basics to practical consequences.
Trache MC; Böttcher A; Betz CS
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):111-117. PubMed ID: 36912223
[TBL] [Abstract][Full Text] [Related]
11. Trimodal (18)F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier.
Treglia G; Ruberto T; Giovanella L
Endocrine; 2016 May; 52(2):397-8. PubMed ID: 25860886
[No Abstract] [Full Text] [Related]
12. Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and to define their diagnostic roles in current scenario.
Arora S; Kumar R; Passah A; Tripathi M; Agarwala S; Khadgawat R; Bal C
Nucl Med Commun; 2019 Dec; 40(12):1230-1242. PubMed ID: 31633647
[TBL] [Abstract][Full Text] [Related]
13. Some Considerations in Treating Malignant Head and Neck Paragangliomas.
Jha A; Nilubol N; Pacak K
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):209-210. PubMed ID: 31725850
[No Abstract] [Full Text] [Related]
14.
Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous Head and Neck Paraganglioma With Distinct Features on 123 I-MIBG and 68 Ga-DOTATATE Images.
Lu Y
Clin Nucl Med; 2022 Sep; 47(9):813-814. PubMed ID: 35353764
[TBL] [Abstract][Full Text] [Related]
16. Paraganglioma of the Head and Neck: A Review.
Sandow L; Thawani R; Kim MS; Heinrich MC
Endocr Pract; 2023 Feb; 29(2):141-147. PubMed ID: 36252779
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
[TBL] [Abstract][Full Text] [Related]
18. Familial paraganglioma.
Işik AC; Erem C; Imamoğlu M; Cinel A; Sari A; Maral G
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):23-31. PubMed ID: 16320027
[TBL] [Abstract][Full Text] [Related]
19. Head and Neck Paragangliomas: An Update on Evaluation and Management.
Moore MG; Netterville JL; Mendenhall WM; Isaacson B; Nussenbaum B
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):597-605. PubMed ID: 26861230
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
